Oruka Therapeutics (ORKA) Total Non-Current Liabilities (2014 - 2025)
Oruka Therapeutics (ORKA) recorded quarterly Total Non-Current Liabilities of $12.8 million in Q3 2025, up 19.55% quarter-over-quarter from $10.7 million in Q2 2025, and up 14.07% on a YoY basis from $11.2 million in Q3 2024.
Oruka Therapeutics (ORKA) Total Non-Current Liabilities (2014 - 2025) Analysis & Trends
Oruka Therapeutics' Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $12.8 million for Q3 2025.
- In Q3 2025, Total Non-Current Liabilities rose 14.07% year-over-year to $12.8 million; the TTM figure through Sep 2025 stood at $12.8 million (up 14.07% YoY), while the FY2015 annual figure was $1.5 million, up 8.12% from the prior year.
- Total Non-Current Liabilities was $12.8 million for Q3 2025 at Oruka Therapeutics, up from $10.7 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $12.8 million in Q3 2025 to a low of $784000.0 in Q3 2023.
- Historically, Total Non-Current Liabilities has averaged $8.0 million across 3 years, with a median of $10.8 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities soared 1328.57% in 2024, then gained 14.07% in 2025.
- A 3-year view of Total Non-Current Liabilities shows it stood at $784000.0 in 2023, then jumped by 1328.57% to $11.2 million in 2024, then gained by 14.07% to $12.8 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $12.8 million (Q3 2025), $10.7 million (Q2 2025), and $11.0 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 64.76 Mn |
| 10 | Oruka Therapeutics | 4.04 Bn | 3.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12.78 Mn |
| Jun 30, 2025 | 10.69 Mn |
| Mar 31, 2025 | 10.97 Mn |
| Sep 30, 2024 | 11.20 Mn |
| Sep 30, 2023 | 784,000.00 |
| Jun 30, 2023 | 1.41 Mn |
| Dec 31, 2015 | 1.50 Mn |
| Dec 31, 2014 | 1.39 Mn |